Literature DB >> 14281538

TREATMENT OF PYELONEPHRITIS: BACTERIAL, DRUG AND HOST FACTORS IN SUCCESS OR FAILURE AMONG 252 PATIENTS.

W R MCCABE, G G JACKSON.   

Abstract

Entities:  

Keywords:  AEROBACTER; ANTIBIOTICS; CHLORAMPHENICOL; COLISTIN; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY; ESCHERICHIA COLI INFECTIONS; KLEBSIELLA; NALIDIXIC ACID; NITROFURANTOIN; PROTEUS INFECTIONS; PSEUDOMONAS INFECTIONS; PYELONEPHRITIS; STATISTICS; SULFONAMIDES; TETRACYCLINE

Mesh：

Substances：

Year:  1965        PMID： 14281538

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Concentration of antibiotics in renal interstitial fluid: an experimental model.

Authors:  H U Eickenberg; N G Waterman; L Scharfenberger
Journal:  Urol Res       Date:  1975-12-30

2.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

3.  Urinary Tract Infections: Resistance Is Futile.

Authors:  Eric Wenzler; Larry H Danziger
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

4.  Experimental Escherichia coli pyelonephritis: formation of spheroplasts in the kidney of the untreated rat.

Authors:  J Demonty
Journal:  Antonie Van Leeuwenhoek       Date:  1970       Impact factor: 2.271

5.  [Determination of renal tissue levels of antibiotics].

Authors:  K Naber; P O Madsen; K H Bichler; D Sauerwein
Journal:  Infection       Date:  1973       Impact factor: 3.553

Review 6.  Cephalosporins in urinary tract infection.

Authors:  L O Gentry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection.

Authors:  Alexandre R Marra; Michael B Edmond; Betty A Forbes; Richard P Wenzel; Gonzalo M L Bearman
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

8.  Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.

Authors:  H Hvidberg; C Struve; K A Krogfelt; N Christensen; S N Rasmussen; N Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

9.  [Typing of Escherichia coli O and K antigens in patients with urinary tract infections (author's transl)].

Authors:  W Sietzen
Journal:  Infection       Date:  1979       Impact factor: 3.553

10.  Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence.

Authors:  Alexandre R Marra; Sérgio B Wey; Adauto Castelo; Ana Cristina Gales; Ruy Guilherme R Cal; José R do Carmo Filho; Michael B Edmond; Carlos Alberto P Pereira
Journal:  BMC Infect Dis       Date:  2006-02-14       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.